News

McKesson To Spin-Off Its Medical-Surgical Solutions Business
McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.
Reuters2y
Baxter to divest biopharma business for $4.25 billion
May 8 (Reuters) - Baxter International Inc (BAX.N), opens new tab ... $0.10 per share in the fourth quarter. The medical device maker's biopharma solutions unit supports drugmakers in the ...
Morningstar2mon
AEON Biopharma, Inc. Announces Reverse Stock Split
Feb. 24, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON ... for debilitating medical conditions, with an initial focus on the neurosciences market. ABP-450 is the same botulinum ...
ETF Daily News1mon
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Position Raised by Prudential Financial Inc.
Xeris Biopharma Holdings, Inc. has a 52-week low of $1.69 and a 52-week high of $6.07. The firm has a market cap of $640.39 million, a P/E ratio of -9.24 and a beta of 1.37. Insider Activity ...
Nasdaq16d
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
Sutro Biopharma, Inc. (STRO) came out with a quarterly loss ... Sutro Biopharma, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $17.4 million for the ...
Finanznachrichten5mon
Immix Biopharma, Inc.: Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed ...
About Immix Biopharma, Inc. Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated ...